Article Versions Notes

Alarcan H, Al Ojaimi Y, Lanznaster D, Escoffre J-M, Corcia P, Vourc’h P, Andres CR, Veyrat-Durebex C, Blasco H. Taking Advantages of Blood–Brain or Spinal Cord Barrier Alterations or Restoring Them to Optimize Therapy in ALS? Journal of Personalized Medicine. 2022; 12(7):1071. https://doi.org/10.3390/jpm12071071

Alarcan, Hugo, Yara Al Ojaimi, Debora Lanznaster, Jean-Michel Escoffre, Philippe Corcia, Patrick Vourc’h, Christian R. Andres, Charlotte Veyrat-Durebex, and Hélène Blasco. 2022. "Taking Advantages of Blood–Brain or Spinal Cord Barrier Alterations or Restoring Them to Optimize Therapy in ALS?" Journal of Personalized Medicine 12, no. 7: 1071. https://doi.org/10.3390/jpm12071071

Alarcan, H., Al Ojaimi, Y., Lanznaster, D., Escoffre, J. -M., Corcia, P., Vourc’h, P., Andres, C. R., Veyrat-Durebex, C., & Blasco, H. (2022). Taking Advantages of Blood–Brain or Spinal Cord Barrier Alterations or Restoring Them to Optimize Therapy in ALS? Journal of Personalized Medicine, 12(7), 1071. https://doi.org/10.3390/jpm12071071